- Home
- GRFS vs RYAN Comparison
GRFS vs RYAN Comparison
Compare GRFS & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- RYAN
- Stock Information
- Founded
- GRFS 1940
- RYAN 2010
- Country
- GRFS Spain
- RYAN United States
- Employees
- GRFS N/A
- RYAN N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- RYAN Specialty Insurers
- Sector
- GRFS Health Care
- RYAN Finance
- Exchange
- GRFS Nasdaq
- RYAN Nasdaq
- Market Cap
- GRFS 7.2B
- RYAN 7.6B
- IPO Year
- GRFS 2006
- RYAN 2021
- Fundamental
- Price
- GRFS $10.72
- RYAN $59.12
- Analyst Decision
- GRFS Hold
- RYAN Buy
- Analyst Count
- GRFS 1
- RYAN 12
- Target Price
- GRFS $10.30
- RYAN $75.10
- AVG Volume (30 Days)
- GRFS 1.3M
- RYAN 1.5M
- Earning Date
- GRFS 01-01-0001
- RYAN 07-31-2025
- Dividend Yield
- GRFS 1.33%
- RYAN 0.81%
- EPS Growth
- GRFS 132.60
- RYAN N/A
- EPS
- GRFS 0.53
- RYAN N/A
- Revenue
- GRFS $8,744,226,659.00
- RYAN $2,754,521,000.00
- Revenue This Year
- GRFS $5.40
- RYAN $27.42
- Revenue Next Year
- GRFS $6.74
- RYAN $16.27
- P/E Ratio
- GRFS $25.84
- RYAN $269.65
- Revenue Growth
- GRFS 9.32
- RYAN 23.84
- 52 Week Low
- GRFS $6.19
- RYAN $55.77
- 52 Week High
- GRFS $11.14
- RYAN $77.16
- Technical
- Relative Strength Index (RSI)
- GRFS 66.35
- RYAN 40.73
- Support Level
- GRFS $10.40
- RYAN $57.16
- Resistance Level
- GRFS $10.84
- RYAN $61.05
- Average True Range (ATR)
- GRFS 0.32
- RYAN 2.04
- MACD
- GRFS -0.04
- RYAN 0.16
- Stochastic Oscillator
- GRFS 73.91
- RYAN 34.63
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.